-
Uncategorized1 day ago
J&J secures right to take the helm in up to $925M Sail CAR T pact
As part of the collaboration, Johnson & Johnson will have an exclusive option to acquire Sail Biomedicines for an additional $2.58 billion.
-
Uncategorized1 day agoEbola outbreak nears milestone, but vaccine is close
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Earlier this week, STAT’s Anil Oza...
-
Uncategorized1 day ago
Sanofi’s new CEO wants more ‘realistic view’ of Phase 3 go/no-go decisions
Sanofi is going to “look very deeply” at its late-stage pipeline as part of a portfolio prioritization initiative, though new CEO Belén Garijo didn’t commit to...
-
Uncategorized1 day ago
Life after the lead asset: Advancing an early-stage pipeline
In this episode of Denatured presented by Arvinas, Jennifer Smith-Parker speaks to Arvinas President and CEO Randy Teel about the strategic discipline and leadership required to...
-
Uncategorized1 day agoSTAT+: Tracking the FDA expert review of Replimune’s melanoma treatment
Welcome to STAT’s live blog of a meeting, convened by the Food and Drug Administration, to review Replimune’s experimental treatment for melanoma. The FDA’s Cellular, Tissue,...
-
Uncategorized2 days agoChronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption
Starting next week, Nebraskans on Medicaid will be at risk of losing their health coverage unless the state can verify that they work, volunteer, or attend...
-
Uncategorized2 days ago
New funding, new jobs: 4 biotechs hiring after series B raises
New funding, new jobs: 4 biotechs hiring after series B raises
-
Uncategorized2 days ago
Not-so-special delivery: When biopharmas fumble layoff news
So far in 2026, over 50 biopharmas have cut or plan to cut their workforces. If they didn’t take a careful, thoughtful approach to telling people...
-
Uncategorized2 days ago
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
-
Uncategorized2 days agoIs it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policy
This story, published in partnership with The Examination, is part of an investigative collaboration involving The Examination, The Bristol Cable, Daraj, Investico, Paper Trail Media, Der...
Capricor CEO won’t rule out legal action against FDA after negative adcomm
Ketamine Triggers Sex-Specific Brain Recovery Responses
